Compounded Semaglutide: What NYC Patients Should Know

Compounded semaglutide is a version of the GLP-1 medication prepared by a compounding pharmacy rather than produced as an FDA-approved branded product like Ozempic or Wegovy. It exists largely because of supply and access factors. For NYC patients, what matters most is understanding how it differs, why sourcing and oversight count, and why physician supervision is essential.

What does "compounded" actually mean?

Compounding is the practice of a licensed pharmacy preparing a medication to meet a specific patient need. Compounded products are not individually FDA-approved the way branded semaglutide is, though compounding pharmacies are regulated. The branded products, semaglutide as Ozempic for type 2 diabetes and Wegovy for chronic weight management, go through full FDA review; compounded versions do not, which is the central distinction patients should understand.

This is not about labeling one option good and another bad. It is about knowing what you are getting and making the decision with a physician.

Why compounded versions became common

Much of the rise in compounded semaglutide traces back to periods when demand for the branded products outpaced supply, leaving some patients unable to fill prescriptions. Compounding pharmacies stepped in to help meet that need. As supply conditions shift over time, the availability and appropriateness of compounded versions can change too, which is one more reason to rely on a physician's current judgment rather than assumptions or what worked for someone else months ago.

Safety and sourcing considerations

Because compounded products vary by pharmacy, sourcing and oversight matter a great deal. A responsible physician will be transparent about where a medication comes from and how it is handled. Things worth understanding:

- Whether the pharmacy is properly licensed and reputable - That compounded products are not individually FDA-approved - That the active ingredient and form should be appropriate and clearly disclosed - That dosing must be physician-directed, never self-adjusted - That any product purchased online without a real evaluation carries added risk

Avoid sources that skip a genuine medical evaluation. A medication that reaches you without a physician reviewing your health is a warning sign, not a convenience.

Why physician supervision is the constant

Whether a program uses a branded or compounded product, the non-negotiable is real medical oversight. GLP-1 medications are prescription treatments that require evaluation, appropriate lab work, and ongoing supervision; they are not appropriate for everyone, and eligibility and contraindications are assessed at consultation. A physician monitors for side effects such as nausea or GI upset that may occur, checks that the medication remains appropriate, and adjusts the plan responsibly over time.

For patients across New York City, the safest path is the same regardless of product type: a thorough evaluation, honest discussion of options, and continuous follow-up.

A transparent, physician-led program in the Flatiron District

At Captivate Medical Wellness, Dr. Marcelo Taborga, MD, a board-certified internist, runs GLP-1 weight-loss programs with genuine medical evaluation and ongoing supervision, and will discuss your options clearly so you can make an informed decision. Care is offered in English and Spanish. The practice is located in Manhattan's Flatiron District, in New York County, convenient to NoMad, Union Square, and the 23rd Street subway stations.

If you are weighing a GLP-1 program and want straightforward, physician-led guidance, schedule a consultation with Captivate Medical Wellness in the Flatiron District of New York City by calling (332) 237-3661.